Arne Scheu net worth
Quick answer
Arne Scheu's estimated net worth is $16.52M (range $11.56M – $24.78M) as of 2026. Arne Scheu is Founder at Valink Therapeutics. Valink Therapeutics valuation.
Arne Scheu is Founder at Valink Therapeutics (YC W21). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Education: PhD, Biochemistry
- Region: United States of America
- Industries: Healthcare, Therapeutics
- Team size: 15
- Website: https://www.valinktx.com/
Who is Arne Scheu?
Arne Scheu is a founder at Valink Therapeutics, which participated in Y Combinator's Winter 2021 batch.
Highlights:
- PhD in Biochemistry
- Harvard University
- Columbia University
About Valink Therapeutics
Valink Therapeutics develops next generation antibody-based therapeutics. We identify novel mechanism of action from known targets by incorporating multiple antibody modifications at once, rapidly and scalable generating complex drug candidates (bi-/multispecificity, multivalency and drug-conjugation in a single discovery process). Our research focus is on solid tumours poorly addressed by immunotherapy.
FAQ: Arne Scheu net worth and Valink Therapeutics valuation
What is Arne Scheu's net worth?
Arne Scheu's estimated net worth is $16.52M (range $11.56M – $24.78M) as of 2026. Arne Scheu is Founder at Valink Therapeutics. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is Valink Therapeutics valuation?
Valink Therapeutics's estimated valuation on Entrepreneurial Check is $118.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Arne Scheu's role?
Arne Scheu is Founder at Valink Therapeutics, a Y Combinator-backed startup (batch W21).